drugset / Trial / NCT04008381
Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid Leukaemia
Phase 1
Unknown
38 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Jinan University, China · collab
NaSingle-groupOpen-labelTreatment
Summary
This study investigates the potential curative properties of ex-vivo expanded gamma delta T-cells obtained from a blood-related donor for patients with relapsed or refractory acute myeloid leukemia.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2022-07-01
- Completion
- 2023-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ex-vivo Expanded γδ T Lymphocytes | Unknown | 2e+06 cells/kg | — |
| Subject | Ex-vivo Expanded γδ T Lymphocytes | Unknown | 4e+06 cells/kg | — |
| Subject | Ex-vivo Expanded γδ T Lymphocytes | Unknown | 8e+06 cells/kg | — |